Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis

ConclusionsUse of smart insulin pens was projected to improve clinical outcomes at lower costs relative to standard care in a Swedish T1D population and represents a good use of healthcare resources in Sweden.

http://link.springer.com/10.1007/s13300-020-00980-1

Source: Diabetes Therapy - December 11, 2020 Category: Endocrinology Source Type: research